Andrew Adams (HC) is a Co-Founder and Managing Partner of Oak HC/FT where he focuses on growth equity and early-stage venture opportunities in Healthcare. Andrew currently serves on the Boards of August Bioservices, DispatchHealth, Galileo, Paladina Health, Therapy Brands, US HealthVest and WithMe Health. He is also a Board Observer at Sema4. Andrew is also actively involved with Independent Living Systems, One Medical Group and Precision Medicine Group. Prior investments include American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Ver...read more